Health authorities blocking change, say PCTs

October 21, 2003

Strategic health authorities are too far removed from PCTs to help them innovate as they work on their plans for …

New lines of communication

October 21, 2003
Medical Communications, Sales and Marketing MHRA, disease awareness campaigns

New guidelines from the Medicines and Healthcare Products Regulatory Agency (MHRA) have placed disease awareness campaigns under the spotlight.They spell …

Are you making the most of your web investment?

October 21, 2003
Medical Communications digi pharma, investment, websites

Pharmaceutical companies have spent millions of pounds on websites since the mid-1990s. Although almost no one is prepared to admit …

Industry careers for pharmacoeconomists

October 21, 2003
Business Services careers, pharmacoeconomists, recruitment

The last five years have seen a shift in pharmacoeconomics to the centre of corporate concerns. Pharmacoeconomics used to be …

Mind the gap

October 20, 2003
Sales and Marketing NHS, healthcare, industry relations

There is a disconnection between what primary care organisation influencers want from a relationship with the pharma industry, and what …

Bringing new drugs to market…at last!

October 20, 2003
Sales and Marketing product launch

In 1987 the average cost of development for new pharmaceutical products was $231 million, and it took between 10 and …

Medicines partnership

October 20, 2003
compliance, medicines partnership, patient

Medicines Partnership was set up by the Department of Health in January 2002 to encourage people to take their medicines …

Measuring your suppliers

October 20, 2003
Business Services IT, measurement, suppliers

When Pharmafocus suggested an article on measuring IT suppliers, this led to much scratching of heads in the Technophobe household.How, …

Recruitment – what’s in it for me?

October 20, 2003
Business Services recruitment

Being 'client focused' is undoubtedly one of the buzz phrases of recent times, but are recruitment companies really focusing on …

Commercial and R&D: reinventing the relationship

October 17, 2003
Research and Development R&D, commercial

Traditionally, pharma companies have been run as research-based organisations relying on well-integrated internal R&D capabilities to feed their commercial pipelines …

On laws and rules of thumb

October 16, 2003
Sales and Marketing digi pharma

This column takes a healthily sceptical (you might say cynical) view of technological innovations, and tends to the view that …

Rebranding – in it for the long haul

October 16, 2003
Medical Communications branding, life cycle

In February, the Government announced plans for a new Hib (Haemophilus influenzae type b) vaccine booster, but with the MMR …

Managing alliances for performance

October 16, 2003
Research and Development alliance

These days no pharmaceutical company would be caught admitting that they did not have an alliance strategy. After all, the …

Communications before launch

October 16, 2003
Medical Communications communications, pre-launch

Producing and launching a profitable drug is no easy task and requires cohesive planning throughout all stages of the product's …

From lab to limousine

October 16, 2003
Research and Development biotech, start-up

Attend any networking conference bringing together fledgling biotechnology companies and investors, whether financial or industry, and you will repeatedly hear …

Power to the patient

October 16, 2003
Medical Communications consumers assocation, patient information

Patient information is a growing issue. Publicity around issues such as the variation in treatment across the country – so-called …

The Gateway to Local Adoption Series

Latest content